Tracheitis treating drug

Abstract

The present invention discloses a tracheitis treating drug, which is prepared from the following raw materials by weight: 8-12 parts of processed ephedra sinica stapf, 8-12 parts of apricot kernel, 8-12 parts of processed aster tataricus, 8-12 parts of stemona japonica, 8-12 parts of asarum sieboldii miq, 8-12 parts of schisandra chinensis, 3-7 parts of dried ginger, 8-12 parts of nepeta cataria l, 8-12 parts of platycodon grandiflorus, 8-12 parts of licorice root, 8-12 parts of rhizoma pinelliae, and 8-12 parts of fructus mume. According to the present invention, the twelve natural traditional Chinese medicines are selected to be subjected to compatibility, various bulk drugs provide the synergetic effect so as to provide effects of sweating, cold removing, lung facilitating, asthma relieving, lung moisturizing, cough stopping, phlegm dissipating, qi depressing, lung heat clearing, heat clearing, qi descending, lung warming, watery phlegm reducing, yin nourishing, phlegm dissipating, pathological fire removing, detoxification, dampness eliminating and the like, the tracheitis treating drug has characteristics of virus and bacterial inhibition, treatment of manifestation and root cause, good tracheitis treating effect, no toxic-side effect, simple preparation method, short treatment course, easy taking, and low cost, and the effective rate is more than or equal to 90%.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating bronchitis. Background technique [0002] Tracheitis is an inflammatory change of the trachea and bronchus mucosa caused by infection or non-infection factors, increased mucus secretion, and the lack of negative ions reduces the activity of respiratory enzymes in the epithelial villi of the tracheal mucosa, affecting the secretion function of the alveoli and the ventilation and exchange of the lungs. Qi function. Clinically, it is characterized by long-term cough, expectoration or accompanied by wheezing. The early symptoms of this disease are mild, and the course of the disease is slow, so it is not noticed by people. If no attention is paid to advanced lesions complicated by obstructive emphysema, lung function will be damaged, affecting health and life. The current commonly used treatment measures use corresponding antibiotics, which can be taken ora...

AI Technical Summary

Problems solved by technology

[0003] Most of these methods can only cure the symptoms but not the root cause. In addition, taking too many antibiotics is harmful to the human body, and the abuse of antibiotics may lead to the strengthening of bacterial resistance and the decline of human immune function, resulting in repeated illnesses that are difficult to heal